KBP Biosciences Lands $76M, an Ex-GlaxoSmithKline Exec as Its New CEO and a HQ Move to Philly Post author:Sam Post published:January 4, 2018 Post category:BioPharma The financing was co-led by Advantech Capital and SDIC Venture Capital. Source: BioSpace You Might Also Like Ignyta Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters??? Option To Purchase Additional Shares May 9, 2017 Pernix Takes the Ax to 22% of Workforce in Reorg January 4, 2018 Riboxx Release: Successful Industrial GMP Manufacturing Of RIBOXXIM, A Novel And Highly Potent Toll-Like 3 Ligand For Immunotherapy Of Cancer September 11, 2017
Ignyta Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters??? Option To Purchase Additional Shares May 9, 2017
Riboxx Release: Successful Industrial GMP Manufacturing Of RIBOXXIM, A Novel And Highly Potent Toll-Like 3 Ligand For Immunotherapy Of Cancer September 11, 2017
